Slides

Learning

Abbr.

1 Develop empiric and definitive antimicrobial therapy

2.

Develop empiric and definitive antimicrobial therapy

SARS-CoV-2

Severe acute respiratory

A.

Acinetobacter spp.

B.

Methicillin-resistant Staphylococcus aureus

C.

Multidrug-resistant Pseudomonas aeruginosa

D.

Streptococcus pneumoniae

🦠 Infectious Diseases I

61

PDF Pages

1+

Objectives

0

Slides

0:00

Duration

0:00 / 0:00

Generating video...

Previous Module

Pharmacoeconomics & Safe Medication Use

Infectious Diseases II